Metraipolis › archive › dc_7ffe628f7496
Efficacy, feasibility, and safety of aquablation after previous urolift treatment of lower urinary tract symptoms secondary to benign prostate hyperplasia: a… — Europe PMC PMID:40900328
- Source
- Europe PMC (en)
- Original
- https://europepmc.org/article/MED/40900328
- DOI
- 10.1007/s00345-[numero omesso]-7
- License (as archived)
- solo-consultazione
- Archived
- 2026-11-10T03:27:56.860Z
- SHA-256 of the archived text
fb065412d2829dae614aef77b043c6d538cedb2b56ac7d09a56c7be9b9df403c- Stable URL of this page
https://metraipolis.com/documento/dc_7ffe628f7496
How to cite
Efficacy, feasibility, and safety of aquablation after previous urolift treatment of lower urinary tract symptoms secondary to benign prostate hyperplasia: a… — Europe PMC PMID:40900328 — Europe PMC (en), https://europepmc.org/article/MED/40900328 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_7ffe628f7496 (Metraipolis archive dc_7ffe628f7496, sha256 fb065412d2829dae614aef77b043c6d538cedb2b56ac7d09a56c7be9b9df403c)
BibTeX
@misc{dc7ffe628f7496,
title = {Efficacy, feasibility, and safety of aquablation after previous urolift treatment of lower urinary tract symptoms secondary to benign prostate hyperplasia: a… — Europe PMC PMID:40900328},
howpublished = {Europe PMC (en)},
url = {https://europepmc.org/article/MED/40900328},
note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_7ffe628f7496; sha256 fb065412d2829dae614aef77b043c6d538cedb2b56ac7d09a56c7be9b9df403c},
year = {2026}
}Archived text
The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40900328. Agents can read the archived copy with the MCP tool read_document.